Investigational Drug Information for Darexaban
✉ Email this page to a colleague
What is the development status for investigational drug Darexaban?
Darexaban is an investigational drug.
There have been 9 clinical trials for Darexaban.
The most recent clinical trial was a Phase 1 trial, which was initiated on April 1st 2009.
The most common disease condition in clinical trials is [disabled in preview]. The leading clinical trial sponsors are Astellas Pharma Inc, Astellas Pharma Europe B.V., and [disabled in preview].
Summary for Darexaban
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 174 |
| WIPO Patent Applications | 110 |
| Japanese Patent Applications | 47 |
| Clinical Trial Progress | Phase 1 (2009-04-01) |
| Vendors | 34 |
Recent Clinical Trials for Darexaban
| Title | Sponsor | Phase |
|---|---|---|
| To Evaluate if Multiple Doses of Ketoconazole Change the Blood Concentration of YM150 (Darexaban) | Astellas Pharma Inc | Phase 1 |
| To Evaluate if Multiple Doses of Rifampicin Change the Blood Concentration of YM150 (Darexaban) | Astellas Pharma Inc | Phase 1 |
| To Evaluate Whether Naproxen and Darexaban (YM150) Interact in Their Effects | Astellas Pharma Inc | Phase 1 |
Clinical Trial Summary for Darexaban
Top disease conditions for Darexaban
Top clinical trial sponsors for Darexaban
US Patents for Darexaban
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
